Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status

被引：0
|
作者：
Bloom, K. J. [1 ]
Ha, T. [1 ]
Uyeda, L. [1 ]
Choppa, P. [1 ]
机构：
[1] Clarient, Aliso Viejo, CA USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1968
引用
收藏
页码：473A / 473A
页数：1
相关论文
共 50 条
  • [1] Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status
    Bloom, K. J.
    Uyeda, L.
    Choppa, P.
    LABORATORY INVESTIGATION, 2012, 92 : 473A - 473A
  • [2] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [3] Mechanism of EGFR and c-Met TKI resistance and role of co-expression of EGFR and c-Met in non-small cell lung cancer patients
    Botting, Gregory Michael
    Harrington, Kymberly
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Arasi, Kavin
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
  • [4] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [5] Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
    Fu, Le
    Guo, Wei
    Liu, Bingshan
    Sun, Linlin
    Bi, Zhenghong
    Zhu, Li
    Wang, Xinyan
    Liu, Bin
    Xie, Qian
    Li, Ke
    BIOMARKERS, 2013, 18 (02) : 126 - 135
  • [6] Brain Metastasis at Diagnosis and EGFR Mutational Status in Non-Small Cell Lung Cancer
    Bhatt, Vijaya R.
    D'Souza, Sanyo P.
    Smith, Lynette
    Cushman-Vokoun, Allison M.
    Noronha, Vanita
    Verma, Vivek
    Joshi, Amit
    Chougule, Anuradha
    Jambekar, Nirmala
    Ganti, Apar K.
    Prabhash, Kumar
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S300 - S300
  • [7] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [8] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [9] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [10] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
12345